New Delhi, Sept. 28 -- India is closely watching US President Donald Trump's latest tariff announcements, even as talks on a US-India Bilateral Trade Agreement (BTA) continue. The US proposal to impose sector- and product-specific tariffs appears at odds with Trump's broader push for bilateral trade deals.

From 1 October, Washington will impose a 100% tariff on branded and patented pharmaceuticals unless the exporting company is already building a plant in the US. Trucks will face a 25% duty, kitchen cabinets and bathroom vanities 50%, and upholstered furniture 30%, likely under the controversial Section 232 national security clause.

The US has already invoked Section 232 of the General Agreement on Tariffs and Trade (GATT) to impose ad...